KATHLEEN SEATON: Open Payments
NPI 1841619582 · MENLO PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 31 payments from 7 companies in 2025. Trend: 2023 $572 · 2024 $458 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $195 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Indivior Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Braeburn Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
Products named: HETLIOZ, REXULTI, SUBLOCADE, CAPLYTA, FANAPT, Auvelity, BRIXADI, VRAYLAR.
Industry payments across CA — which companies pay providers there.
